Effects of recombinant human growth hormone on remnant liver after hepatectomy in hepatocellular carcinoma with cirrhosis

Table 2 Comparison of liver function, blood glucose, serum prealbumin and transferrin

Normal control group (n = 12)		PN group (n = 12)			rhGH+PN group (n = 12)
		Preoperative	POD 1	POD 6	Preoperative	POD 1	POD 6
AST (IU/L)	26.0 ± 5	56.0 ± 27a	761.0 ± 578	62.0 ± 32	55.0 ± 25a	578.0 ± 206	56.0 ± 25
ALT (IU/L)	27.0 ± 17	60.0 ± 36a	749.0 ± 571	153.0 ± 95	42.0 ± 17a	590.0 ± 273	154.0 ± 71
ALP (IU/L)	94.0 ± 55	151.0 ± 87	145.0 ± 80	148.0 ± 65	105.0 ± 27	100.0 ± 33	113.0 ± 46
TBIL (µmol/L)	17.4 ± 6.4	22.6 ± 9.0	52.5 ± 48.1	43.1 ± 37.4	20.5 ± 9.3	42.1 ± 41.6	30.2 ± 21.0
ALB (g/L)	42.8 ± 4.0	39.8 ± 4.7	31.5 ± 3.3	34.0 ± 3.4	40.7 ± 3.5	32.4 ± 3.6	37.1 ± 5.0
Blood glucose (mmol/L)	4.6 ± 0.6	4.8 ± 0.9	7.3 ± 3.5	5.3 ± 1.5	4.5 ± 0.6	7.0 ± 3.2	8.8 ± 5.2c
Serum prealbumin (mg/L)	279.8 ± 43.0	202.4 ± 32.3a	158.3 ± 25.4	127.2 ± 13.4	204.5 ± 31.9a	157.2 ± 23.0	156.4 ± 20.0c
Serum transferrin (g/L)	3.5 ± 0.5	2.5 ± 0.2a	2.1 ± 0.3	1.8 ± 0.2	2.5 ± 0.2a	2.2 ± 0.3	2.2 ± 0.3c

^aP < 0.05, preoperative vs normal control group;

^cP < 0.05, between rhGH + PN group and PN group.